Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

The healthcare leader is also an excellent income stock. Johnson & Johnson has increased its dividend payout for 62 ...

A class action filed today says Kiwis have been deceived for about two decades through the use of phenylephrine in cold and ...

A major lawsuit filed on Thursday says pharmaceutical giant Johnson & Johnson has misled customers for decades about the ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

A class action lawsuit launched in Auckland today questioning Johnson and Johnson cold and flu products follows similar suits ...

Some might describe Johnson & Johnson's business as boring, but sometimes, that's not such a bad thing. Selling pharmaceutical products is a steady and reliable business even when the economy is ...

Bryan Johnson raised strong concerns about the supplement industry's profit-driven practices and lack of transparency on ...

Johnson & Johnson (NYSE:JNJ) ranks eighth on our list of the most promising stocks according to hedge funds. The New ...

Other Hispanic supermarket brands include El Mercado Fresco, a locally owned outfit that will soon open a spot in Olathe at ...